Exact Mass: 472.3916
Exact Mass Matches: 472.3916
Found 500 metabolites which its exact mass value is equals to given mass value 472.3916,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Soyasapogenol D
Soyasapogenol D is a triterpenoid. Soyasapogenol D is a natural product found in Glycine max, Medicago sativa, and other organisms with data available. See also: Trifolium pratense flower (part of). Soybean saponin (from Glycine max). Soyasapogenol D is found in pulses. Soyasapogenol D is found in pulses. Soybean saponin (from Glycine max)
alpha-Tocopherol acetate
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols Vitamin E supplement and antioxidant for foodstuffs Vitamin E supplement and antioxidant for foodstuff D018977 - Micronutrients > D014815 - Vitamins Same as: D01735 D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1]. D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].
Leucettamol A
3alpha,21beta-dihydroxy-11alpha-methoxy-olean-12-ene
3??-Methoxy-9??,19-cyclolanost-23(E)-en-25,26-diol
(+)-(20S)-20-(dimethylamino)-16alpha-hydroxy-3beta-(3alpha-isopropyl)-lactam-5alpha-pregn-4-one
(22S,24R)-24-methyllanosta-8-en-22,28-epoxy-3beta,22alpha-diol
(3alpha,22S,25R,26R)-26-methoxy-22,26-epoxylanost-8-en-3-ol|artabotryol C1
Me ester-25-Hydroxy-3, 4-secocycloart-23-en-3-oic acid
dammarenolic acid methyl ester|Dammarenolsaeure-methylester
24-methylenecycloartane-3beta,16beta,23beta-triol|longitriol
Me ester-24-Hydroxy-3, 4-secocycloart-25-en-3-oic acid
cupacinoxepin (5aR,8aR,9aR,10aS,13bR,14bR,17bS,18bS)-4,4,8a,10a,14b,18b,22,22-octamethylperhydronaphtho[1,2-e]benzo[1,2-b:4,3-c]dioxepin-3-one
(3beta,4alpha,5alpha,8beta)-4-methylergost-24(28)-ene-3,8-diol 3-monoacetate
3beta,15alpha,26,27-tetrahydroxy-5alpha-lanosta-7,9(11),24-trien|ganodermatetraol
(24E,3beta,22alpha)-3,22-dihydroxylanosta-8,24-dien-26-oic acid|astraodoric acid C
3,4-seco-29-nortirucalla-4,23-dione-7-ene-3-oic acid 3-methyl ester|aphanamgrandin H
cycloartan-24(24a)-ene-1a,2a,3b?triol|neomacrotriol
3beta,7beta,25-trihydroxycucurbita-5,(23E)-dien-19-al
6beta-hydroxybetulinic acid|6??-Hydroxybetulinic acid
(20S,23S)-3beta,20-dihydroxyldammarane-24-ene-21-oic acid-21, 23-lactone
(5alpha,6beta,15beta,22E)-6-ethoxy-5,15-dihydroxyergosta-7,22-dien-3-one
(17R,20R)-27,29-dihydroxycycloart-24-en-3-olide|(1R,3aS,3bS,5aR,10aR,11aS,13aR)-tetradecahydro-6-(hydroxymethyl)-1-[(2R,5Z)-7-hydroxy-6-methylhept-5-en-2-yl]-3a,6,13a-trimethyl-8H-cyclopenta[5,6]cyclopropa[1,8a]naphtho[2,1-c]oxepin-8-one|gummiferartane-8
3alpha-hydroxy-2-oxo-D:A-friedooleanan-28-ioic acid|3alpha-hydroxy-2-oxo-D:A-friedooleanan-28-oic acid
5alpha-lanosta-7,9(11)-diene-3beta,25-diol-28-carboxylic acid|sexangulic acid
11-Ac-3beta-3,11-Dihydroxy-9,11-secoergosta-5,24(28)-dien-9-one|3beta-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one
6beta,12-dihydroxy-11alpha-methoxy-24-norurs-12-en-3-one
(3beta,22beta)-3,22,24-Trihydroxy-12-oleanen-19-one|3beta,22beta,24-Trihydroxyolean-12-en-19-on|Sapogenin III
3beta,28alpha-dihydroxy-16-oxo-13beta,28-oxydooleanane
(22E)-6-O-butylcholesta-7,22-diene-3beta,5alpha,6beta-triol|homaxisterol A1
24-methylenecholestan-3-one-5alpha,6beta-diol-6-acetate
3beta,21beta,22beta-trihydroxyurs-12-en-28-al|cordianal C
(23R,24E)-3beta,23-dihydroxy-9beta-lanosta-7,24-dien-26-oic acid|abiesatrine F
20,24-Epoxy-24-methoxy-23(24-25)abeo-dammaran-3-one
(3beta,22R,23S)-24-Methylenelanost-8-ene-3,22,23-triol
2beta,3beta-dihydroxy-D:C-friedoolean-8-en-29-oic acid|2beta-hydroxybryonolic acid
3alpha,21beta-dihydroxy-11alpha-methoxy-urs-12-ene
20alpha-dimethylamino-3beta-(3,4-dimethylpent-3-enoyl)amino-5alpha-pregnane-4beta-ol|pachysamine P
20-Me ether-3,20-Dihydroxy-30-nor-12-oleanen-28-oic acid
22alpha-methoxyfaradiol|22alpha-methoxytaraxast-20-ene-3beta,16beta-diol
6beta-acetoxy-(22E)-ergosta-7,22-diene-3beta,5alpha-diol|6??-Acetoxy-(22E)-ergosta-7,22-diene-3??,5??-diol
Ganodermanontriol
Ganodermanontriol is a triterpenoid. It has a role as a metabolite. Ganodermanontriol is a natural product found in Ganoderma leucocontextum, Ganoderma sinense, and other organisms with data available. A natural product found in Ganoderma lucidum.
(5R,5aS,7aR,7bR,9aR,13aR,13bS,15aR,15bR)-icosahydro-15a-(hydroxymethyl)-5,5a,7b,9a,12,12,13b-heptamethylchryseno[1,2-d]oxepine-2,4-dione|2,3-seco-2,3-epoxy-25-hydroxy-2,3-friedelanedione|lobatanhydride
3,7,25-Trihydroxycucurbita-5,23-dien-19-al
3beta,7beta,25-Trihydroxycucurbita-5,23-dien-19-al is a natural product found in Momordica charantia with data available.
Maytenfolic acid
Triptotriterpenic acid A is a pentacyclic triterpenoid with formula C30H48O4, originally isolated from Tripterygium hypoglaucum. It has a role as a plant metabolite. It is a pentacyclic triterpenoid, a hydroxy monocarboxylic acid and a diol. It derives from a hydride of an oleanane. Triptotriterpenic acid A is a natural product found in Euonymus laxiflorus, Salacia chinensis, and other organisms with data available. A pentacyclic triterpenoid with formula C30H48O4, originally isolated from Tripterygium hypoglaucum.
60HAB1ZK1T
Pomolic acid is a triterpenoid. It has a role as a metabolite. Pomolic acid is a natural product found in Freziera, Debregeasia saeneb, and other organisms with data available. See also: Sanguisorba officinalis whole (part of). A natural product found particularly in Rosa woodsii and Euscaphis japonica. Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2]. Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2].
Alisol B
Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions. IC50 Value: Target: In vitro: The in vitro cultured human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. Exogenous C3a could induce renal tubular EMT. Alisol B was capable of suppressing C3a induced EMT [1]. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways, alisol-B inhibited the phosphorylation of JNK, which are upregulated in response to RANKL in bone marrow macrophages, alisol-B also inhibited RANKL-induced expression of NFATc1 and c-Fos, which are key transcription factors for osteoclastogenesis. In addition, alisol-B suppressed the pit-forming activity and disrupted the actin ring formation of mature osteoclasts [2]. Alisol B induced calcium mobilization from internal stores, leading to autophagy through the activation of the CaMKK-AMPK-mammalian target of rapamycin pathway. Moreover, the disruption of calcium homeostasis induces endoplasmic reticulum stress and unfolded protein responses in alisol B-treated cells, leading to apoptotic cell death. Finally, by computational virtual docking analysis and biochemical assays, it was showed that the molecular target of alisol B is the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase [3]. In vivo: Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions. IC50 Value: Target: In vitro: The in vitro cultured human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. Exogenous C3a could induce renal tubular EMT. Alisol B was capable of suppressing C3a induced EMT [1]. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways, alisol-B inhibited the phosphorylation of JNK, which are upregulated in response to RANKL in bone marrow macrophages, alisol-B also inhibited RANKL-induced expression of NFATc1 and c-Fos, which are key transcription factors for osteoclastogenesis. In addition, alisol-B suppressed the pit-forming activity and disrupted the actin ring formation of mature osteoclasts [2]. Alisol B induced calcium mobilization from internal stores, leading to autophagy through the activation of the CaMKK-AMPK-mammalian target of rapamycin pathway. Moreover, the disruption of calcium homeostasis induces endoplasmic reticulum stress and unfolded protein responses in alisol B-treated cells, leading to apoptotic cell death. Finally, by computational virtual docking analysis and biochemical assays, it was showed that the molecular target of alisol B is the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase [3]. In vivo:
Sumaresinolic acid
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.531 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.529 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.540 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.537
C30H48O4_(2alpha,3beta,5xi,9xi,18xi)-2,3-Dihydroxyolean-12-en-28-oic acid
C30H48O4_(2alpha,3beta,5xi,9xi,13xi,18xi)-2,3-Dihydroxylup-20(29)-en-28-oic acid
Alpha-Tocopherol Acetate
Alpha-Tocopherol acetate is a tocol. D-alpha-tocopheryl acetate appears as odorless off-white crystals. Darkens at 401 °F. (NTP, 1992) - National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina. Alpha-tocopherol is the primary form of vitamin E that is preferentially used by the human body to meet appropriate dietary requirements. In particular, the RRR-alpha-tocopherol (or sometimes called the d-alpha-tocopherol stereoisomer) stereoisomer is considered the natural formation of alpha-tocopherol and generally exhibits the greatest bioavailability out of all of the alpha-tocopherol stereoisomers. Moreover, RRR-alpha-tocopherol acetate is a relatively stabilized form of vitamin E that is most commonly used as a food additive when needed. Alpha-tocopherol acetate is subsequently most commonly indicated for dietary supplementation in individuals who may demonstrate a genuine deficiency in vitamin E. Vitamin E itself is naturally found in various foods, added to others, or used in commercially available products as a dietary supplement. The recommended dietary allowances (RDAs) for vitamin E alpha-tocopherol are: males = 4 mg (6 IU) females = 4 mg (6 IU) in ages 0-6 months, males = 5 mg (7.5 IU) females = 5 mg (7.5 IU) in ages 7-12 months, males = 6 mg (9 IU) females = 6 mg (9 IU) in ages 1-3 years, males = 7 mg (10.4 IU) females = 7 mg (10.4 IU) in ages 4-8 years, males = 11 mg (16.4 IU) females = 11 mg (16.4 IU) in ages 9-13 years, males = 15 mg (22.4 IU) females = 15 mg (22.4 IU) pregnancy = 15 mg (22.4 IU) lactation = 19 mg (28.4 IU) in ages 14+ years. Most individuals obtain adequate vitamin E intake from their diets; genuine vitamin E deficiency is considered to be rare. Nevertheless, vitamin E is known to be a fat-soluble antioxidant that has the capability to neutralize endogenous free radicals. This biologic action of vitamin E consequently continues to generate ongoing interest and study in whether or not its antioxidant abilities may be used to help assist in preventing or treating a number of different conditions like cardiovascular disease, ocular conditions, diabetes, cancer and more. At the moment however, there exists a lack of formal data and evidence to support any such additional indications for vitamin E use. Vitamin E Acetate is the acetate ester of a fat-soluble vitamin with potent antioxidant properties. Considered essential for the stabilization of biological membranes (especially those with high amounts of polyunsaturated fatty acid), vitamin E is a generic name for a group of compounds known as tocopherols and tocotrienols (tocols). This agent is a potent peroxyl radical scavenger and inhibits noncompetitively cyclooxygenase activity in many tissues, resulting in a decrease in prostaglandin production. Vitamin E also inhibits angiogenesis and tumor dormancy through suppressing vascular endothelial growth factor (VEGF) gene transcription. (NCI04) A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture. D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols D018977 - Micronutrients > D014815 - Vitamins Same as: D01735 D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1]. D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].
Alfacol
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols D018977 - Micronutrients > D014815 - Vitamins D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1]. D-α-Tocopherol acetate (D-Vitamin E acetate) can be hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].
(5Z,7E)-(1S,3R)-26,27-diethyl-23-oxa-9,10-seco-5,7,10(19),20-cholestatetraene-1,3,25-triol
1β-butyl-1α,25-dihydroxyvitamin D3 / 1β-butyl-1α,25-dihydroxycholecalciferol
1α-butyl-1β,25-dihydroxyvitamin D3 / 1α-butyl-1β,25-dihydroxycholecalciferol
26,27-diethyl-1α,25-dihydroxyvitamin D3 / 26,27-diethyl-1α,25-dihydroxycholecalciferol
(5Z,7E)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol
Lucidumol A
Queretaroic acid
Priverogenin A
(3beta,23xi)-3,23-Dihydroxycycloart-24-en-26-oic acid
Pomolic acid
Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2]. Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from?Euscaphis japonica?(Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)[2].
20B-hydroxyursolic acid
Azukisapogenol
D-Maslinic acid
Sebiferenic acid
Momordicin I
Constituent of leaves and vines of Momordica charantia (bitter melon). Momordicin I is found in bitter gourd and fruits.
Ganoderic acid U
Epoxyganoderiol A
3,22-Dihydroxycycloart-24-en-26-Oic acid
Albigenic acid
Rubitic acid
Ganoderiol E
3alpha-Corosolic acid
ascr#38
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (20R)-20-hydroxyhenicosanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#38
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 21-hydroxyhenicosanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
1beta-butyl-1alpha,25-dihydroxyvitamin D3 / 1beta-butyl-1alpha,25-dihydroxycholecalciferol
1alpha-butyl-1beta,25-dihydroxyvitamin D3
26,27-diethyl-1alpha,25-dihydroxyvitamin D3 / 26,27-diethyl-1alpha,25-dihydroxycholecalciferol
1alpha,25-dihydroxy-26,27-dimethyl-24a,24b-dihomovitamin D3
Ganodermatriol
Constituent of Ganoderma lucidum (reishi). Ganodermatriol is found in mushrooms.
(2beta,3alpha)-2,3-Dihydroxy-urs-12-en-28-oic acid
(4S)-2α,3β-Dihydroxy-D:C-friedo-B:A-neogammacer-9(11)-en-23-oic acid
Cochalic acid
A pentacyclic triterpenoid that is oleanane which has been substituted by hydroxy groups at the 3beta and 16beta positions, dehydrogenated to introduce a double bond at the 12-13 position, and in which the methyl substituent at position 17 has undergone oxidation to give the corresponding carboxylic acid. Found in the cactus Myrtillocactus cochal.
4-Epihederagenin
A pentacyclic triterpenoid that is the C-4 epimer of hederagenin. It has been isolated from the roots of Rubia yunnanensis.
fatsicarpain E
A pentacyclic triterpenoid that is olean-18-ene substituted by alpha-hydroxy groups at positions 3 and 11 respectively and a carboxy group at position 28. It has been isolated from the leaves and twigs of Fatsia polycarpa.
21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heneicosanoic acid
(20R)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicosanoic acid
Hederagenol
Hederagenin is a triterpenoid saponin that can inhibit the expression of iNOS, COX-2, and NF-κB in cells caused by LPS stimulation. Hederagenin is a triterpenoid saponin that can inhibit the expression of iNOS, COX-2, and NF-κB in cells caused by LPS stimulation.
Pulchinenoside A_qt
23-hydroxybetulinic acid is one of the bioactive components responsible for its anticancer activity. In vitro: 23-hydroxybetulinic acid also shows different proliferation inhibitory activity against B16, HeLa, and HUVEC, with the IC50 value of 78.5, 80, and 94.8 uM, respectively. 23-hydroxybetulinic acid can promote cell cycle arrest at S phase and induce apoptosis via intrinsic pathway. 23-hydroxybetulinic acid disrupts mitochondrial membrane potential significantly (p<0.01) and selectively downregulates the levels of Bcl-2, survivin and upregulates Bax, cytochrome C, cleaved caspase-9 23-hydroxybetulinic acid can induce apoptosis in K562 cells. [1] 23-hydroxybetulinic acid enhances sensitivity of doxorubicin (DOX, ADR) on MCF-7/ADR cell lines, indicating its potential to be developed as a novel MDR modulator.[2] 23-HBA significantly improve the sensitivity of the tumor to doxorubicin. [3] 23-hydroxybetulinic acid is one of the bioactive components responsible for its anticancer activity. In vitro: 23-hydroxybetulinic acid also shows different proliferation inhibitory activity against B16, HeLa, and HUVEC, with the IC50 value of 78.5, 80, and 94.8 uM, respectively. 23-hydroxybetulinic acid can promote cell cycle arrest at S phase and induce apoptosis via intrinsic pathway. 23-hydroxybetulinic acid disrupts mitochondrial membrane potential significantly (p<0.01) and selectively downregulates the levels of Bcl-2, survivin and upregulates Bax, cytochrome C, cleaved caspase-9 23-hydroxybetulinic acid can induce apoptosis in K562 cells. [1] 23-hydroxybetulinic acid enhances sensitivity of doxorubicin (DOX, ADR) on MCF-7/ADR cell lines, indicating its potential to be developed as a novel MDR modulator.[2] 23-HBA significantly improve the sensitivity of the tumor to doxorubicin. [3]
Echinocystic acid
Echinocystic acid is a pentacyclic triterpene extracted from the fruit of Honey Locust. It has strong antioxidant, anti-inflammatory and anti-tumor properties. Echinocystic acid is a pentacyclic triterpene extracted from the fruit of Honey Locust. It has strong antioxidant, anti-inflammatory and anti-tumor properties.
(17-hydroxy-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-1-yl) dodecanoate
[3-Carboxy-2-(3-hydroxyicosanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(2-hydroxyicosanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(12-hydroxyicosanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(15-hydroxyicosanoyloxy)propyl]-trimethylazanium
TRIPTOTRITERPENIC ACID C
A pentacyclic triterpenoid with formula C30H48O4, originally isolated from the roots of Tripterygium wilfordii.
2alpha,3beta-Dihydroxyolean-13(18)-en-28-oic acid
A pentacyclic triterpenoid that is olean-13(18)-en-28-oic acid substituted by hydroxy groups at positions 2 and 3 (the 2alpha,3beta-stereoisomer). It has been isolated from the leaves of Rosa laevigata.
(4aS,6aS,6bR,10R,11R,12aR)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
3beta-hydroxyfriedelan-23-oic acid
A natural product found in Garcia parviflora.
(1R,3aS,5aR,5bR,9R,10R,11aR)-9,10-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
[(2R)-3-carboxy-2-(18-carboxyoctadecanoyloxy)propyl]-trimethylazanium
(2α,3β)-2,3-Dihydroxylup-20(29)-en-28-oic acid
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] pentanoate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] propanoate
2-Trimethylsilyloxyicosanoic acid trimethylsilyl ester
[1-carboxy-3-[3-[(E)-hexadec-7-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
Soyasapogenol D
Soyasapogenol D is a triterpenoid. Soyasapogenol D is a natural product found in Glycine max, Medicago sativa, and other organisms with data available. See also: Trifolium pratense flower (part of).
Tocopheryl acetate
D020011 - Protective Agents > D000975 - Antioxidants > D024505 - Tocopherols D018977 - Micronutrients > D014815 - Vitamins
4,5,10-Trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbaldehyde
(3b,22S,24E)-3,22-Dihydroxycycloart-24-en-26-oic acid
(1r,4r,5r,8s,10s,13r,14r,17r,18r,19s,20s)-10-hydroxy-19-(2-hydroxypropan-2-yl)-4,5,9,9,13-pentamethyl-21-oxahexacyclo[18.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricosan-22-one
(1s,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14br)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(4as,6as,6br,8ar,10r,11r,12ar,12bs,14bs)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1r,3ar,5ar,7s,9as,10r,11ar)-7,10-dihydroxy-1-[(5e)-7-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(3as,5ar,5br,7as,11ar,11bs,13ar,13br)-1-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a-pentamethyl-9-oxo-tetradecahydro-1h-cyclopenta[a]chrysene-3a-carboxylic acid
(3s,4as,6as,6br,8ar,10r,12as,12br,13r,14br)-13-methoxy-2,2,4a,6a,6b,9,9,12a-octamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,10-diol
(4as,6as,6br,10s,11r,12ar)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1r,3as,3br,4s,7s,9as,9bs,11ar)-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
(1r,3as,5ar,5br,7ar,9s,10r,11ar,11br,13ar,13br)-9,10-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
10-hydroxy-2-(hydroxymethyl)-2,4a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
(2r,4as,6as,6br,8ar,9r,10r,12ar,12br,14br)-10-hydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
(2s,4ar,5s,6as,6br,8ar,10s,12ar,12br,14bs)-5,10-dihydroxy-2-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carbaldehyde
4,7-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,6,6,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(1s,3s,5r,7r,10s,11r,14s,15r,18s,20r)-7-hydroxy-18-methoxy-1,6,6,10,15,19,19-heptamethylpentacyclo[12.8.0.0³,¹¹.0⁵,¹⁰.0¹⁵,²⁰]docosane-3-carbaldehyde
(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl docosanoate
1-(6-hydroperoxy-6-methylhept-4-en-2-yl)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(1r,2s,3ar,5ar,9as,11ar)-2-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-one
(1s,6r,8s,11r,12s,15s,16r,19s,20s,21r)-8,19-dihydroxy-20-(hydroxymethyl)-1,7,7,11,16,20-hexamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-5-one
(2r,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-4a-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
2-[(1z,2s,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1s,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal
n-[(1s,3as,3bs,5ar,6r,7s,9ar,9bs,11as)-6-(acetyloxy)-9a,11a-dimethyl-1-[(1s)-1-(methylamino)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid
(1s,4s,5r,8r,10s,13r,14r,16r,17s,18r)-10,16-dihydroxy-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-23-one
(1s,2r,5s,7s,10r,11r,14r,15s,16s,18s,20s)-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosane-7,16-diol
(1r,4s,5r,8s,11r,13r,14s,17r,18s,21r,24r)-21-hydroxy-5,8,11,14,17,24-hexamethyl-22-oxahexacyclo[19.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosane-11-carboxylic acid
(2s,3r,5s)-5-[(1s)-1-[(1r,3ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-isopropyloxolan-2-ol
(1s,2s,3as,5ar,9ar,9br,11as)-2-hydroxy-1-[(1r,2s,3r)-2-hydroxy-3-(2-hydroxypropan-2-yl)cyclopentyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(1r,3as,3bs,4s,7s,9as,9br,11ar)-4,7-dihydroxy-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
2-{7,9-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid
4-methoxy-2,3-dimethyl-6-[(2e,7r,11r)-3,7,11,15-tetramethylhexadec-2-en-1-yl]phenyl acetate
4,6-dihydroxy-7,12,16-trimethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(1s,6r,7s,8s,11r,12s,15s,16r,19s,21r)-7-(hydroxymethyl)-19-methoxy-1,7,11,16,20,20-hexamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-ol
7,10-dihydroxy-1-(7-hydroxy-6-methylhept-5-en-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one
(1s,3as,5ar,9ar,9br,11as)-1-[(1r)-1-[(2s,3s)-3-[(1s)-1,2-dihydroxy-2-methylpropyl]oxiran-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
9,12-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
[(1r,3as,3bs,4s,7s,9as,9bs,11ar)-4,7-dihydroxy-11a-methyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate
2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal
1-(5,6-dimethylhept-3-en-2-yl)-5a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
(3ar,9as,9bs)-1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(2r,4ar,6ar,6br,8as,10r,12ar,12bs,14br)-10-hydroxy-2-(hydroxymethyl)-2,4a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
1,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2s,4r,4ar,6br,10s,12ar,14bs)-4,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
(1s,3ar,3br,5ar,9as,9bs,10r,11as)-10-hydroxy-1-[(2s,5r)-5-isopropyl-2,5-dimethyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
9,23-dimethyl-30-oxa-11,25-diazapentacyclo[20.6.2.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³¹]hentriacontan-8-one
(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r)-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-2,10-diol
(1s,6r,8r,11r,12r,15s,16r,19r,20s,21r)-8,19-dihydroxy-20-(hydroxymethyl)-1,7,7,11,16,20-hexamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-5-one
(2s,4as,6ar,6bs,8as,9r,11r,12as,12bs,14as,14br)-11-hydroxy-2,4a,6a,8a,9,12b,14a-heptamethyl-10-oxo-tetradecahydro-1h-picene-2-carboxylic acid
(4ar,5s,6as,6br,10s,12ar,12br,14br)-5,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1r,2s,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
4,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid
3-[3-(5-isopropyl-2,5-dimethyloxolan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
10-hydroxy-9-(hydroxymethyl)-2,2,4a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
(1s,2r,4as,6as,6br,8as,10s,12as,14ar,14br)-10,14a-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,5,6,7,8,8a,10,11,12,12b,14b-tetradecahydropicene-4a-carboxylic acid
2-(5-hydroxy-3-methylpent-3-en-1-yl)-6-[(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-1-methyl-3-methylidenecyclohexane-1-carboxylic acid
(2r,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-2-(hydroxymethyl)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(3ar,3bs,5ar,9as,9bs,10s)-1-[(2r,4s,5s)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(5as,6r,7r,9as)-6-{2-[(4ar,6r,8as)-6-hydroxy-2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4h-naphthalen-1-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-4h-1-benzoxepin-3-one
(1r,3s,6s,8s,11r,12s,15r,16s,19r,21s)-8-methoxy-3,7,7,11,16,20,20-heptamethyl-24-oxahexacyclo[13.8.1.0¹,¹⁵.0³,¹².0⁶,¹¹.0¹⁶,²¹]tetracosan-19-ol
1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybut-2-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(3as,3bs,5ar,9as,9br,10s)-1-[(2s,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
2-[4-hydroxy-3-(hydroxymethyl)-2-(3-hydroxypropyl)-4-methyl-3-(4,8,12-trimethyltrideca-3,5,7,11-tetraen-1-yl)cyclohexylidene]propanal
2-[(1r,2s,5r)-2-[(2s,6s,8as)-6-hydroxy-8a-methyl-1-oxo-2,3,5,6,7,8-hexahydronaphthalen-2-yl]-5-[(2r,5r)-5,6-dimethylhept-3-en-2-yl]-1-methylcyclopentyl]ethyl acetate
(1r,2r,3r,6r,9r,10r,13s,14r)-13-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-2,5,5,9,10-pentamethyl-4-oxotetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecane-3-carbaldehyde
(4ar,6ar,6br,8r,10s,12ar,12br,14br)-8,10-dihydroxy-2,2,4a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-6a-carboxylic acid
(1s,4as,6br,10r,12ar)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1s,3r,6s,8r,11s,12s,14s,15r,16r)-15-[(2s,4s)-4-hydroxy-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-6,14-diol
(1r,3as,3bs,4s,7s,9as,9bs,11ar)-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
(1r,3ar,5ar,7r,9as,11ar)-1-[(1s)-1-[(2s,5r,6r)-6-methoxy-5-methyloxan-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
1-[1-(3,4-dihydroxy-5,5-dimethyloxolan-2-yl)ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-3,5,10-triol
(2r,3s,5z,8z,11z,14z,17z,20z,28s,29r)-2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol
(2z,5r,7e,11e)-2-[(4z)-6-hydroxy-4-(hydroxymethyl)hex-4-en-1-ylidene]-8,12,16-trimethyl-5-(prop-1-en-2-yl)heptadeca-7,11,15-trienoic acid
(1s,3ar,3br,5ar,9as,9br,10r,11ar)-10-hydroxy-1-[(2r)-2-hydroxy-6-methyl-4-oxohept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
4,7-dihydroxy-1-(4-hydroxy-6-methylhept-5-en-2-yl)-3a,6,6,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-9-hydroxy-1-(3-hydroxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
3-[(3s,3ar,5ar,6s,7s,9ar,9br)-3-[(2s,5r)-5-isopropyl-2,5-dimethyloxolan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
1-[5-(1-hydroxy-2-methylpropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol
(1r,3as,3br,4s,7s,9as,9bs,11ar)-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-ol
1-[(1s,2s,3as,3br,5ar,6r,7r,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2,6-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-3-(propan-2-ylidene)azetidin-2-one
13α,14α-epoxy-3β-methoxyserratan-21β-ol
{"Ingredient_id": "HBIN001128","Ingredient_name": "13\u03b1,14\u03b1-epoxy-3\u03b2-methoxyserratan-21\u03b2-ol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "CC1(C2CCC34CC5(CCC6C(C(CCC6(C5CCC3(C2(CCC1O)C)O4)C)OC)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
13β,l4β-epoxy-3β-methoxyserratan-21β-ol
{"Ingredient_id": "HBIN001140","Ingredient_name": "13\u03b2,l4\u03b2-epoxy-3\u03b2-methoxyserratan-21\u03b2-ol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "CC1(C2CCC34CC5(CCC6C(C(CCC6(C5CCC3(C2(CCC1O)C)O4)C)OC)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
14β,15β-epoxy-3β-methoxyserratan-21β-ol
{"Ingredient_id": "HBIN001378","Ingredient_name": "14\u03b2,15\u03b2-epoxy-3\u03b2-methoxyserratan-21\u03b2-ol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
22alpha-methoxyfaradiol
{"Ingredient_id": "HBIN003680","Ingredient_name": "22alpha-methoxyfaradiol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "CC1C2C3CCC4C5(CCC(C(C5CCC4(C3(CC(C2(C(C=C1C)OC)C)O)C)C)(C)C)O)C","Ingredient_weight": "472.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9979;16250","PubChem_id": "10390082","DrugBank_id": "NA"}
3-methoxycycloart-23-ene-25,26-diol
{"Ingredient_id": "HBIN008823","Ingredient_name": "3-methoxycycloart-23-ene-25,26-diol","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "NA","Ingredient_weight": "472.74","OB_score": "NA","CAS_id": "142950-85-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8058","PubChem_id": "NA","DrugBank_id": "NA"}
4'-hydroxy-cis-cinnamicacid docosyl ester
{"Ingredient_id": "HBIN010529","Ingredient_name": "4'-hydroxy-cis-cinnamicacid docosyl ester","Alias": "NA","Ingredient_formula": "C31H52O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15820","TCMID_id": "9908","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
